Novartis AG is 48.1x more valuable than RHYTHM PHARMACEUTICALS, INC. by market capitalization ($282.64 B vs $5.87 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RYTM | NVS |
|---|---|---|
| Market cap | $5.87 B | $282.64 B |
| US-listed rank | #1281 | #47 |
| Revenue (latest FY) | $189.76M | - |
| Net income (latest FY) | -$196.54K | - |
| Net margin | -0.1% | - |
| SEC filings | 799 | 947 |
Novartis AG is 48.1x more valuable than RHYTHM PHARMACEUTICALS, INC. by market capitalization ($282.64 B vs $5.87 B).
Full pages: RHYTHM PHARMACEUTICALS, INC. and Novartis AG, or browse the full rankings.